Roy A. Bakay Functional Neurosurgery Lectureship
-
October 31, 2025
Clinical Scorecard: Roy A. Bakay Functional Neurosurgery Lectureship
At a Glance
| Category | Detail |
|---|---|
| Condition | Neurological disorders including movement disorders and Parkinson's disease |
| Key Mechanisms | Functional neurosurgery techniques such as deep brain stimulation (DBS) and convection enhanced delivery (CED) for gene therapy |
| Target Population | Patients with movement disorders and neurological diseases amenable to neurosurgical intervention and gene therapy |
| Care Setting | Specialized neuroscience institutes and academic medical centers with clinical trial capabilities |
Key Highlights
- Pioneering work in deep brain stimulation initiated by Dr. Roy A. Bakay and colleagues.
- Development and refinement of convection enhanced delivery techniques for nervous system gene therapy.
- Ongoing clinical trials supported by significant NIH funding aiming to deliver biological products for Parkinson's disease.
Guideline-Based Recommendations
Diagnosis
- Utilize clinical evaluation and movement disorder assessment to identify candidates for functional neurosurgery.
- Consider genetic and molecular diagnostics when planning gene therapy interventions.
Management
- Employ deep brain stimulation for movement disorders as established by early human trials.
- Use convection enhanced delivery to administer viral vector-based gene therapies targeting neurological conditions.
- Integrate clinical trial protocols to ensure safety and efficacy in novel therapeutic approaches.
Monitoring & Follow-up
- Long-term follow-up to assess gene expression persistence and clinical outcomes.
- Monitor for immune responses and adverse effects related to viral vector delivery.
Risks
- Potential immune reactions to viral vectors as highlighted by historical adverse events.
- Risks inherent to neurosurgical procedures including infection, hemorrhage, and neurological deficits.
Patient & Prescribing Data
Patients enrolled in clinical trials for gene therapy and functional neurosurgery interventions.
Gene therapy using viral vectors can provide long-term gene expression; however, safety and immune response remain critical considerations.
Clinical Best Practices
- Conduct multidisciplinary evaluation including neurology, neurosurgery, and genetics before intervention.
- Implement convection enhanced delivery techniques with precision to maximize therapeutic gene distribution.
- Maintain rigorous clinical trial standards to monitor safety and efficacy of emerging therapies.
- Educate patients on the experimental nature and potential risks of gene therapy approaches.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
